Immuron (IMRN) Non-Current Deferred Tax Liability (2022 - 2024)
Immuron (IMRN) posted quarterly Non-Current Deferred Tax Liability of $28000.0 for Q4 2024, down 80.78% year-over-year from $145663.0 in Q1 2024, and down 80.78% quarter-over-quarter from $145663.0 in Q4 2023.
Immuron (IMRN) Non-Current Deferred Tax Liability (2022 - 2024) Analysis & Trends
Immuron's Non-Current Deferred Tax Liability history runs 3 years deep, the most recent figure standing at $28000.0 for Q4 2024.
- In Q4 2024, Non-Current Deferred Tax Liability fell 80.78% year-over-year to $28000.0; the TTM figure through Dec 2024 stood at $28000.0 (down 80.78% YoY), while the FY2024 annual figure was $28000.0, down 80.78% from the prior year.
- Non-Current Deferred Tax Liability for Q4 2024 stood at $28000.0, down from $145663.0 in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $698195.0 in Q2 2023, with the low at $28000.0 in Q4 2024.
- The 3-year median for Non-Current Deferred Tax Liability is $145663.0 (2023), against an average of $242010.1.
- The sharpest annual moves came in 2023 and 2024: Non-Current Deferred Tax Liability soared 394.68% in 2023, then plunged 80.78% in 2024.
- Immuron's Non-Current Deferred Tax Liability stood at $197051.0 in 2022, then dropped by 26.08% to $145663.0 in 2023, then slumped by 80.78% to $28000.0 in 2024.
- Business Quant data shows IMRN's Non-Current Deferred Tax Liability at $28000.0 in Q4 2024, $145663.0 in Q4 2023, and $698195.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Immuron | 6.75 Mn | 6.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 28,000.00 |
| Dec 31, 2024 | 28,000.00 |
| Dec 31, 2023 | 145,663.00 |
| Dec 31, 2023 | 145,663.00 |
| Jun 30, 2023 | 698,195.00 |
| Jun 30, 2023 | 698,195.00 |
| Dec 31, 2022 | 197,051.00 |
| Dec 31, 2022 | 197,051.00 |
| Jun 30, 2022 | 141,141.39 |
| Jun 30, 2022 | 141,141.39 |